Articles related to DEVICE/DRUG APPROVALS
Elranatamab, Now Elrexfio, Approved for Hard-to-treat Myeloma
Hematology/Oncology September 5th 2023
Peer-influenced content. Sources you trust. No registration required. This is HCN.
Hematology/Oncology September 5th 2023